Schistosomiasis Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Site (Intestinal, Urogenital); Drug Type (Praziquantel, Metrifonate, Oxamniquine) and Geography
Report Code: TIPRE00008459 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Schistosomiasis is an acute and chronic disease caused by parasitic worms. According to, WHO Estimates it shows that at least 220.8 million people required preventive treatment for schistosomiasis in 2020, out of which more than 102.3 million people were reported to have been treated. There are 2 major forms of schistosomiasis intestinal and urogenital caused by 5 main species of blood fluke. Currently only three drugs are used on a global scale for the treatment of schistosomiasis: praziquantel, metrifonate, and oxamniquine.
MARKET DYNAMICS
The factors that drive the growth of the global drugs for schistosomiasis market include rise in prevalence of schistosomiasis, lack of safe drinking water and lack of hygiene in developing countries. However, lack of awareness about the treatment may restrain the market growth. Furthermore, strategic initiatives taken by healthcare authorities, such as WHO, which is working with partners and the private sector and has sponsored for increased access to praziquantel and resources for implementation are anticipated to offer lucrative opportunities it the forecast period.
MARKET SCOPE
`
The "Global Drugs for Schistosomiasis Market analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Drugs for Schistosomiasis Market with detailed market segmentation by site, drug type and geography. The Global Drugs for Schistosomiasis Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Drugs for Schistosomiasis Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Global Drugs for Schistosomiasis Market is segmented on the basis of site and drug type. On the basis of site, the market is segmented into intestinal and urogenital. On the basis of drug type the market is segmented into praziquantel, metrifonate, and oxamniquine ?
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Drugs for Schistosomiasis Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Drugs for Schistosomiasis Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Drugs for Schistosomiasis market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drugs for Schistosomiasis Market in these regions.
The report covers key developments in the Drugs for Schistosomiasis Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Drugs for Schistosomiasis Market are anticipated to lucrative growth opportunities in the future with the rising demand for Drugs for Schistosomiasis Market in the global market. Below mentioned is the list of few companies engaged in the Drugs for Schistosomiasis Market.
The report also includes the profiles of key Drugs for Schistosomiasis Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Shin Poong Pharma.Co., Ltd.
- Merck & Co., Inc.
- Bayer AG
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Schistosomiasis is an acute and chronic disease caused by parasitic worms. According to, WHO Estimates it shows that at least 220.8 million people required preventive treatment for schistosomiasis in 2020, out of which more than 102.3 million people were reported to have been treated. There are 2 major forms of schistosomiasis intestinal and urogenital caused by 5 main species of blood fluke. Currently only three drugs are used on a global scale for the treatment of schistosomiasis: praziquantel, metrifonate, and oxamniquine.
MARKET DYNAMICS
The factors that drive the growth of the global drugs for schistosomiasis market include rise in prevalence of schistosomiasis, lack of safe drinking water and lack of hygiene in developing countries. However, lack of awareness about the treatment may restrain the market growth. Furthermore, strategic initiatives taken by healthcare authorities, such as WHO, which is working with partners and the private sector and has sponsored for increased access to praziquantel and resources for implementation are anticipated to offer lucrative opportunities it the forecast period.
MARKET SCOPE
`
The "Global Drugs for Schistosomiasis Market analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Drugs for Schistosomiasis Market with detailed market segmentation by site, drug type and geography. The Global Drugs for Schistosomiasis Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Drugs for Schistosomiasis Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Global Drugs for Schistosomiasis Market is segmented on the basis of site and drug type. On the basis of site, the market is segmented into intestinal and urogenital. On the basis of drug type the market is segmented into praziquantel, metrifonate, and oxamniquine ?
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Drugs for Schistosomiasis Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Drugs for Schistosomiasis Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Drugs for Schistosomiasis market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drugs for Schistosomiasis Market in these regions.
The report covers key developments in the Drugs for Schistosomiasis Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Drugs for Schistosomiasis Market are anticipated to lucrative growth opportunities in the future with the rising demand for Drugs for Schistosomiasis Market in the global market. Below mentioned is the list of few companies engaged in the Drugs for Schistosomiasis Market.
The report also includes the profiles of key Drugs for Schistosomiasis Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Shin Poong Pharma.Co., Ltd.
- Merck & Co., Inc.
- Bayer AG
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies
1. Shin Poong Pharma.Co., Ltd.
2. Merck & Co., Inc.
3. Bayer AG
1. Shin Poong Pharma.Co., Ltd.
2. Merck & Co., Inc.
3. Bayer AG
Get the Latest COVID-19 Analysis on this market
Have a Question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount